Stepan Q2 Sales and EBITDA Jump, But 100 Job Cuts and Soft Q3 Warning Loom
SCL sits 53% above its 52-week low of $41.82.
Summary
Stepan posted a strong Q2 rebound with sales and EBITDA gains driven by organic volume, favorable mix, higher prices, and Project Catalyst savings. This follows a brutal Q1 that included a $65.4M restructuring charge and a $41.4M net loss. The company is now cutting about 100 salaried roles and expects $75–$80M in additional restructuring charges, with $14–$18M in cash costs, mostly in H2 2026. Management warned Q3 will be somewhat lower, tempering the positive Q2 momentum. Leadership changes include a director resignation and a new Principal Accounting Officer. The restructuring signals serious cost discipline, but the soft Q3 guidance and ongoing charges keep the outlook mixed.
At the time of this announcement, SCL was trading at $64.14 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $41.82 to $68.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.